Solving the organ shortage: potential strategies and the likelihood of success.
The discrepancy between the demand and supply of organs for clinical transplantation remains a major problem. The current incidence of end-stage renal disease results in a patient population that doubles every decade. However, there have been no advancements in developing a comparable increase in the number of available allografts. There are three potential approaches to solving the shortage. In the near-term, the development of technology to access the pool of warm ischemically damaged organs may represent a solution. To achieve this goal, it will be necessary to develop technology that mimics the physiologic processes of wound repair. Alternatively, it has been proposed that an increased supply of organs can be developed with xenografts. To make xenotransplantation a clinical reality, it will be necessary to overcome the barriers that exist in nature between the species. Recent work in the area of stem cell research has provided evidence supporting the potential of generating biohybrid organs. A major undertaking of this emerging field will be to develop the ability to define and control the differentiation processes involved in organ specificity. The following is a review of the current status and relative issues involved with these three potential approaches to solving the organ shortage.